Orvosi hetilap, 2014-04, Vol.155 (16), p.607-614
2014
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Clinical significance of and treatment options for increased lipoprotein(a)
- Ist Teil von
- Orvosi hetilap, 2014-04, Vol.155 (16), p.607-614
- Ort / Verlag
- Hungary
- Erscheinungsjahr
- 2014
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Lipoprotein(a) has been shown to be associated with an increased incidence of cardiovascular diseases for decades. However, only recent research revealed more about its physiological function and its role in the development of cardiovascular diseases. The authors summarize the physiological role of lipoprotein(a), causes and treatment of elevated lipoprotein(a) level, and the association between lipoprotein(a) and cardiovascular diseases.
- Sprache
- Ungarisch
- Identifikatoren
- ISSN: 0030-6002eISSN: 1788-6120DOI: 10.1556/OH.2014.29877Titel-ID: cdi_pubmed_primary_24733102
- Format
- –
- Schlagworte
- Aspirin - therapeutic use, Biomarkers - blood, Blood Component Removal, Cardiovascular Diseases - blood, Cardiovascular Diseases - etiology, Carrier Proteins - antagonists & inhibitors, Cholesterol Ester Transfer Proteins - antagonists & inhibitors, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use, Hyperlipoproteinemias - blood, Hyperlipoproteinemias - complications, Hyperlipoproteinemias - therapy, Hypolipidemic Agents - therapeutic use, Lipoprotein(a) - blood, Lipoprotein(a) - genetics, Niacin - therapeutic use, Oligonucleotides - therapeutic use, Proprotein Convertase 9, Proprotein Convertases - antagonists & inhibitors, Risk Factors, Serine Endopeptidases